Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| InformAI | 2025 | Grant | $465K | Houston |
| Reconstruct | 2025 | Venture - Series Unknown | Undisclosed | Menlo Park |
| Remedium Bio | 2026 | Venture - Series Unknown | Undisclosed | Needham |
| Levisonics Inc | 2026 | Grant | $15K | Fishers |
| Impressio | 2023 | Grant | $250K | Denver |
| Optipulse | 2024 | Equity Crowdfunding | $11K | Albuquerque |
| Gencores | 2025 | Grant | $100K | Boston |
| Micro-Leads | 2025 | Grant | $100K | Somerville |
| Eascra Biotech | 2025 | Grant | $100K | Boston |
| Nanopath | 2025 | Grant | $100K | Cambridge |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 401 | InformAI | Grant | $465K | Houston, United States |
| 402 | Reconstruct | Venture - Series Unknown | Undisclosed | Menlo Park, United States |
| 403 | Remedium Bio | Venture - Series Unknown | Undisclosed | Needham, United States |
| 404 | Levisonics Inc | Grant | $15K | Fishers, United States |
| 405 | Impressio | Grant | $250K | Denver, United States |
| 406 | Optipulse | Equity Crowdfunding | $11K | Albuquerque, United States |
| 407 | Gencores | Grant | $100K | Boston, United States |
| 408 | Micro-Leads | Grant | $100K | Somerville, United States |
| 409 | Eascra Biotech | Grant | $100K | Boston, United States |
| 410 | Nanopath | Grant | $100K | Cambridge, United States |
InformAI delivers AI-enabled clinical solution focused on oncology and diagnostic imaging to improve patient outcomes.
Reconstruct builds a platform that provides actionable analytics to construction managers enabling them to make better decisions.
Remedium Bio is a gene therapy company focused on the development of highly innovative treatments for a broad range of diseases.
Levisonics is a manufacturer of blood coagulation devices created to perform non-contact analysis of blood coagulation.
Imprressio is focusing on developing ultra-dissipative materials for protective equipment such as helmet liners and paddings.
Optipulse designs and manufactures wireless communication equipment.
Gencores provides a platform that reduces the risk of concussion with customizable, smart, shock-absorbing helmet inserts.
Micro-Leads Medical is a medical technology company dedicated to developing innovative therapies that address the neuromodulation.
Eascra Biotech develops DNA nanostructures to create stable nanomaterials for biomedical applications.
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
Emvolon is a technology company that converts wasted resources into low-cost green fuels
Theromics is a medical device company advancing novel technologies for interventional radiology and drug delivery.
Aspero Medical is developing an endoscopic device that can be used by doctors treating patients with gastrointestinal diseases.
Proov offers the most advanced system for women to evaluate their hormones at home, built upon patented, FDA cleared medical devices.
Auxilium Health is creating low-cost, smart biomaterials for difficult-to-heal wounds.
NeuroFlow is a HIPAA compliant digital health platform that optimizes the way behavioral healthcare is delivered, tracked, and assessed.
Geometric Data Analytics is a research, development and consulting company.
BrilliantMD is a provider of claims management software for the healthcare sector.
Clue Genetics is a business services company.
Circle Optics has developed the world's first parallax-free 360-degree camera. We can capture 4K 360-degree video without post-processing.
Phosio Corporation creates materials used to deposit metal oxides at low temperatures.
Caporus develops novel thin-film dielectrics.
Encapsulate is a biotechnology company that offers precision diagnostics for cancer therapy.
DIANT Pharma develops continuous processing technology for nanoparticle drug products and vaccines.
Abalone Bio develops pharmacologically antibody drugs to successfully treat metaolic and inflammatory diseases where other drugs fail
National Science Foundation has invested in 2,544 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Science Foundation's top investment sectors include Health Care, Biotechnology, Medical Device, Medical, Analytics. The firm invests across 45 different industry categories.
Among tracked funding rounds, Abalone Bio received $7.6M in a Seed round. National Science Foundation's total known invested capital is $6.8B.
National Science Foundation's average investment size is $5.9M across its portfolio of 2,544 companies.
Recent National Science Foundation portfolio additions include InformAI, Reconstruct, Remedium Bio, Levisonics Inc, Impressio. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors